LETTER TO THE EDITORS Letter: increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti‐TNFα agents, particularly etanercept, for autoimmune diseases other than IBD Cong Dai E-mail address: congdai2006@sohu.com https://orcid.org/0000-0003-1317-183X Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China Search for more papers by this author PDF PDF Share Abstract...